Results 231 to 240 of about 3,942,953 (265)

Spatial Transcriptomics Reveals a T Cell‐Mediated Microglial Activation Axis of Immune Checkpoint Inhibition‐Related Adverse Events in the Brain

open access: yesAdvanced Science, EarlyView.
Immune checkpoint inhibition (ICI) reshapes the hippocampal neuroimmune niche. Spatial transcriptomic profiling and human brain histological analyses identify neuroinflammation and altered neuronal and glial programs. Notably, T cell depletion prevents ICI‐driven microglial activation, establishing the T cell–microglia crosstalk axis as a driving ...
Devyani Swami   +7 more
wiley   +1 more source

A Metabolic‐Epigenetic Axis of AARS1/IGF2BP3‐K280 Lactylation Sustains Endometrial Cancer Stemness and Recurrence

open access: yesAdvanced Science, EarlyView.
Lactate‐driven endometrial cancer relapse is mediated by enzymatic protein modification. Elevated lactate levels activate AARS1, which catalyzes K280 lactylation of IGF2BP3, therefore stabilizing HMGA2 mRNA and promoting tumor stemness and recurrence.
Peng Jiang   +11 more
wiley   +1 more source

PTBP1‐Mediated Alternative Splicing of DNAJB6 Promotes Everolimus Resistance in Clear Cell Renal Cell Carcinoma via EIF4B/PKIB/AKT/mTOR Positive Feedback Loop

open access: yesAdvanced Science, EarlyView.
PTBP1‐mediated alternative splicing drives a pathogenic switch to the DNAJB6b isoform in everolimus‐resistant clear cell renal cell carcinoma. This splicing event programs a positive feedback loop including EIF4B/PKIB/AKT/mTOR, promoting aggressive therapy resistance.
Xiu‐wu Pan   +18 more
wiley   +1 more source

Cofilin1-driven cytoskeletal remodeling modulates pan-cancer CD8<sup>+</sup> T cell immunotherapy responses. [PDF]

open access: yesCell Rep Med
Li L   +24 more
europepmc   +1 more source

<i>CDKN2AIPNL</i>: a potential pan-cancer biomarker. [PDF]

open access: yesFront Genet
Yuan Y   +6 more
europepmc   +1 more source

ICIsAtlas reveals a suppressive NK cell niche in pan-cancer immunotherapy profiles. [PDF]

open access: yesCommun Biol
Xie Y   +16 more
europepmc   +1 more source

Pan-cancer investigation identifies ARL4A as a prospective therapeutic indicator for thyroid cancer. [PDF]

open access: yesDiscov Oncol
Men Y   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy